Grifols takes part in the exhibition "Molecules of Life: 50 years of Biochemistry and Molecular Biology in Spain"
- Grifols sponsors the module dedicated to "Plasma Proteins" which consists of an augmented reality system
- The National Natural Science Museum , which belongs to the Spanish National Research Council (CSIC), welcomes the exhibition until January
Barcelona, Sept. 4, 2013.- Starting yesterday until January 19, the National Natural Science Museum, which belongs to the Spanish National Research Council (CSIC), welcomes the exhibition Molecules of Life: 50 years of Biochemistry and Molecular Biology in Spain. This temporary exhibition seeks to bring basic educational concepts of Biochemistry and Molecular Biology to the general public in the form of an interactive tour of the basic molecules we find in our every day lives, such as those that make up the human body.
Among the different modules on display, one focuses on the "Molecules of the Sea" sponsored by the Spanish biotechnology company Zeltia and another module deals with "Antifungal Molecules", sponsored by MSD. Grifols sponsors the module dedicated to "Plasma Proteins" which consists of an augmented reality system that allows visitors to interact onscreen with three-dimensional images of the different proteins contained in plasma. The system shows the role that these proteins play in the proper functioning of the body and what happens if they appear in insufficient quantities or are missing. The module aims to describe the importance of these proteins, how they are recovered from blood or plasma donations and the essential processes in which they are involved, such as coagulation, fighting infections, and capturing toxins for elimination.
The exhibition is part of a series of activities organized by the Spanish Society of Biochemistry and Molecular Biology to celebrate its fiftieth anniversary. After passing through Madrid, the exhibition will continue its tour of various science museums throughout Spain.
¿What is plasma?
Plasma is the liquid portion of blood, and accounts for 55% of total blood volume. It consists mainly of water and proteins, the most important of which are immunoglobulins (or antibodies), clotting factors and albumin. Of the 5 liters of blood contained in the human body, almost 3 liters are plasma. Plasma proteins have therapeutic properties. These are treated and purified to create the plasma products used to treat congenital conditions and other critical blood diseases.
Grifols is a global healthcare company with a 70-year legacy of improving people's health and well being through the development of life-saving plasma medicines, hospital pharmacy products and diagnostic technology for clinical use.
As a leading producer of plasma medicines, Grifols has a presence in more than 100 countries and is the world leader in plasma collection, with 150 plasma donation centers across the U.S. Grifols is committed to increasing patient access to its life-saving plasma medicines through significant manufacturing expansions and the development of new therapeutic applications of plasma proteins. The company is headquartered in Barcelona, Spain and employs more than 11,000 people worldwide.
In 2012, Grifols' sales exceeded 2,620 million euros. The company's class A shares are listed on the Spanish Stock Exchange, where they are part of the Ibex-35 (MCE:GRF). Its non-voting class B shares are listed on the Mercado Continuo (MCE:GRF.P) and on the U.S. NASDAQ via ADRs (NASDAQ: GRFS). For more information visit www.grifols.com